2022-04-12 - Cancer Synoptic Reporting Project Group Meeting Virtual Business Meeting
Cancer Synoptic Reporting Project Group
12 April 2022 at 14:00 - 16:30 UTC
Attendees
@Scott Campbell @Suzanne Santamaria @Elaine Wooler @r.dash (Unlicensed) @Stefan Dubois (Unlicensed) @Laszlo Igali (Unlicensed) @Paul (Unlicensed) @Jim Case @Anna Rossander (Unlicensed) @Former user (Deleted) @Sharon Sebastian (Unlicensed) @Former user (Deleted)
@Thomas Ruediger (Unlicensed) @Nicola Ingram
Meeting Recording (GoogleDrive)
https://drive.google.com/file/d/1iTFcIC9iwR_Ur-4i8lTHvous_8QC-bZT/view?usp=sharing
Discussion items
Item | Description | Owner | Notes | Action |
|---|
Item | Description | Owner | Notes | Action |
|---|---|---|---|---|
1 | Tumor deposits (Review) | @Scott Campbell |
|
 2. Melanoma (microsatellite) - Definition needs to stay primitive as definition of discontinuous spread from one part of the skin to another part of the skin structure AND within 2 cm cannot be modelled with necessary and sufficient conditions Possible to have process to extend to lymphatic vessel structure of skin. Suggest hierarchy of concepts. In-transit melanoma to be primitive for now. Potential to include concrete domains to define such characteristics but must be discussed further. |
2 | Tumor bud (Review) | @Scott Campbell | Will leave as primitive....no way to model "cluster of cells at leading edge of invasive component of neoplasm" |
Agreed.
|
3 | Patterns | @Scott Campbell |
| Discussion surrounding morphologies and additional descriptors. Histologies are authoritative based on pathologist interpretation. Morphologic descriptors are subsequent phenotypic characteristics of the primary histology. Consider using qualifier values for growth patterns in protocols where required as supplemental/additional information to the actual histology |
4 | Treatment effect | @Scott Campbell | Continue discussion: What are we measuring when assessing "treatment effect"? Is this a histologic change? Viability of tumor cells?
|
Not discussed. |
5 | Lung tumor focality; synchronous | @Scott Campbell |
| Group suggests that we take the approach of soliciting location of nodules by lobe, and then the logic of the forms and/or sidedness can be stated and/or calculated. |
6 | Implementation workshop | @Scott Campbell | Discuss interest in a session on implementation and use | Strong agreement. Paul Seegers, Stefan Dubois, Jim Campbell, Raj Dash, Laszlo Iglali all willing to be co-faculty |
7 | Histology taxonomy | @Scott Campbell | Interest in revisiting with pathologists | Strong interest here and supported by SNOMED Intl. Must coordinate work with Nikki Ingram's work. |
8 | Additional work items as time allows | @Scott Campbell |
| N/A |
Meeting Files
Previous Meetings
| Title | Creator | Modified |
|---|---|---|
| No content found. | ||